# Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers

> **NCT02529800** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HIP1402
- **DRUG:** HGP0412

## Key facts

- **NCT ID:** NCT02529800
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02529800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02529800, "Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02529800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*